Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug 6:10:228.
doi: 10.1186/1475-2875-10-228.

Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar

Tong-Soo Kim  1 , Hyung-Hwan Kim, Jung-Yeon Kim, Yoon Kong, Byoung-Kuk Na, Khin Lin, Sung-Ung Moon, Yeon-Joo Kim, Myoung-Hee Kwon, Youngjoo Sohn, Hyuck Kim, Hyeong-Woo Lee
Affiliations

Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar

Tong-Soo Kim et al. Malar J. .

Abstract

Background: The aim of this study was to investigate the profile of antibodies against several antigens of Plasmodium vivax and Plasmodium falciparum in Mandalay, Myanmar.

Methods: Malaria parasites were identified by microscopic examination. To test the antibodies against P. vivax and P. falciparum in sera, an indirect immunofluorescence antibody test (IFAT) was performed using asexual blood parasite antigens. An enzyme-linked immunosorbent assay (ELISA) was performed with circumsporozoite protein (CSP), Pvs25 and Pvs28 recombinant proteins of transmission-blocking vaccine candidates for P. vivax, and liver stage specific antigen-1 and -3 (PfLSA-1, PfLSA-3) for P. falciparum.

Results: Fourteen patients among 112 were found to be infected with P. vivax and 26 with P. falciparum by thick smear examination. Twenty-three patients were found to be infected with P. vivax, 19 with P. falciparum and five with both by thin smear examination. Blood samples were divided into two groups: Group I consisted of patients who were positive for infection by microscopic examination, and Group II consisted of those who showed symptoms, but were negative in microscopic examination. In P. falciparum, IgG against the blood stage antigen in Group I (80.8%) was higher than in Group II (70.0%). In P. vivax, IgG against the blood stage antigen in Group I (53.8%) was higher than in Group II (41.7%). However, the positivity rate of the PvCSP VK210 subtype in Group II (40.0%) was higher than in Group I (23.1%). Similarly for the PvCSP VK247 subtype, Group II (21.7%) was higher than that for Group I (9.6%). A similar pattern was observed in the ELISA using Pvs25 and Pvs28: positive rates of Group II were higher than those for Group I. However, those differences were not shown significant in statistics.

Conclusions: The positive rates for blood stage antigens of P. falciparum were higher in Group I than in Group II, but the positive rates for antigens of other stages (PfLSA-1 and -3) showed opposite results. Similar to P. falciparum, the positive rate of pre-blood stage (CSP VK210 and 247 subtype) and post-blood stage (Pvs25 and 28) antigens of P. vivax were higher in Group II than in Group I. Therefore, sero-diagnosis is not helpful to discriminate between malaria patients and symptomatic individuals during the epidemic season in Myanmar.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study areas in Mandalay, Myanmar. A: Sedaw Gyi; B: Kyauk Me; C: Pyin Oo Lwin; D: Wet Won.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Vector Borne Diseases Control Project-Department of Health. Annual Report Myanmar. 1997.
    1. Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature. 1987;329:164–167. doi: 10.1038/329164a0. - DOI - PubMed
    1. Aidoo M, Lalvani A, Gilbert S, Hu JT, Daubersies P, Hurt N, Whittle HC, Druilhe P, Hill AVS. Cytotoxic T-lymphocyte epitopes for HLA-B-53 and other HLA types in the malaria vaccine candidate liver stage antigen 3. Infect Immun. 2000;68:227–232. doi: 10.1128/IAI.68.1.227-232.2000. - DOI - PMC - PubMed
    1. Joshi SK, Bharadwaj A, Chatterjee S, Chauhan VS. Analysis of immune response against T-and B-cell epitopes from Plasmodium falciparum liver stage antigen 1 in rodent malaria models and malaria exposed human subject in India. Infect Immun. 2000;68:141–150. doi: 10.1128/IAI.68.1.141-150.2000. - DOI - PMC - PubMed
    1. Perlaza BL, Sauzet JP, Balde AT, Brahimi K, Tall A, Corradin G, Druilhe P. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent induces of B helper, T helper and cytolytic T cell responses in mice. Eur J Immunol. 2001;31:2200–2209. doi: 10.1002/1521-4141(200107)31:7<2200::AID-IMMU2200>3.0.CO;2-L. - DOI - PubMed

Publication types